Frankfurt
07.04.26 | 08:18
4,240 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,280 | 4,740 | 15:05 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.03. | ACACIA RESEARCH CORP - 10-K, Annual Report | 3 | SEC Filings | ||
| ACACIA RESEARCH Aktie jetzt für 0€ handeln | |||||
| 11.03. | Acacia Research signals $2M annualized cost savings from Deflecto plant consolidation while maintaining $340M cash and securities | 2 | Seeking Alpha | ||
| 11.03. | ACACIA RESEARCH CORP - 8-K, Current Report | 1 | SEC Filings | ||
| 10.03. | Acacia Research Q4 2025 Earnings Preview | 1 | Seeking Alpha | ||
| 06.02. | ACACIA RESEARCH CORP - 8-K, Current Report | 18 | SEC Filings | ||
| 05.11.25 | Acacia Research Non-GAAP EPS of -$0.01 beats by $0.13, revenue of $59.4M beats by $21.4M | 3 | Seeking Alpha | ||
| 05.11.25 | ACACIA RESEARCH CORP - 8-K, Current Report | 1 | SEC Filings |
7 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 18,700 | +5,29 % | Formycon-CEO im AKTIONÄR-Interview: "Die FDA sendet sehr klare Signale" (Teil 1) | Der deutsche Biosimilar-Entwickler Formycon musste zuletzt erneut den Bilanzansatz für FYB202 anpassen. Zudem kündigte die Gesellschaft an, die Veröffentlichung des Geschäftsberichts zu verschieben... ► Artikel lesen | |
| ONTO INNOVATION | 201,90 | +6,80 % | Onto Innovation: Cantor Fitzgerald erhöht Kursziel aufgrund positiver Gewinnaussichten | ||
| NVE | 61,00 | -0,81 % | Dividendenbekanntmachungen (02.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY INC US00508Y1029 0,2 USD 0,1687 EUR ALLY FINANCIAL INC US02005N1000 0,3 USD 0,2531 EUR AMERISERV FINANCIAL INC US03074A1025 0... ► Artikel lesen | |
| RIBER | 6,470 | +9,66 % | RIBER delivers strong earnings growth in 2025 | RIBER delivers strong earnings growth in 2025 Revenues: €40.3m (-2%)Income from ordinary operations: €5.1m, representing 13% of revenues Net income: €5.2m (+27%)Proposed payout of €0.10 per share... ► Artikel lesen | |
| SOLESENCE | 1,220 | 0,00 % | Solésence, Inc.: Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results | Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty... ► Artikel lesen | |
| GOMSPACE | 1,546 | +5,31 % | GomSpace Group AB: GomSpace Secures 1.8 MEUR (19.9 MSEK) of Products order intake in Q1 2026 | GomSpace has received orders from more than 25 customers for a total of 1.8 MEUR (19.9 MSEK), aligned with the target for the quarter.
PRESS RELEASE
Stockholm
01 april 2026
GomSpace Secures 1.8... ► Artikel lesen | |
| GAUZY | 0,720 | 0,00 % | GAUZY LTD: Gauzy Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | TEL AVIV, Israel, March 20, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on March 17... ► Artikel lesen | |
| VEECO INSTRUMENTS | 31,000 | +2,65 % | Axcelis Technologies, Inc.: Axcelis Stockholders Approve Merger with Veeco | BEVERLY, Mass., Feb. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) ("Axcelis") today announced that its stockholders have voted to approve all... ► Artikel lesen | |
| KOPIN | 2,335 | +7,21 % | Kopin Corporation: Michael Murray, Kopin's CEO to Present at THEON International's Capital Markets Day (CMD) on November 6, 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| ZENTEK | 0,486 | +1,67 % | Zentek Ltd.: Zentek Engages ICP Securities Inc. for Automated Market Making Services | Guelph, Ontario--(Newsfile Corp. - April 1, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is pleased to announce that it has engaged ICP Securities Inc. ("ICP") to provide... ► Artikel lesen | |
| OBDUCAT | 0,005 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| DOTZ NANO | 0,018 | -1,64 % | DOTZ NANO LIMITED: Cleansing Notice | ||
| ADVANCE ZINCTEK | 0,494 | 0,00 % | Advance ZincTek Reports Strong Sales Growth and Critical Mineral Status | ||
| NANOVIRICIDES | 0,865 | +8,80 % | Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides | SHELTON, CT / ACCESS Newswire / April 7, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of... ► Artikel lesen | |
| REGION GROUP | 1,318 | -0,21 % | REGION GROUP: Update - Notification of buy-back - RGN |
Das Unternehmen ACACIA RESEARCH CORPORATION kann der Branche Nanotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 4,240 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACACIA RESEARCH CORPORATION finden Sie auf Wallstreet Online.